Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001829126-25-007499
Filing Date
2025-09-18
Accepted
2025-09-18 16:33:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A novabay_defa14a.htm DEFA14A 17990
2 EXHIBIT 99.1 novabay_ex99-1.htm EX-99.1 13052
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5996
  Complete submission text file 0001829126-25-007499.txt   40461
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 251323884
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)